Effects of respiratory chain inhibitors on mitochondrial ATPase activity.
D000251:Adenosine Triphosphatases / Q000378:metabolism*; D000654:Amobarbital / Q000494:pharmacology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000968:Antimycin A / Q000494:pharmacology; D001562:Benzimidazoles / Q000494:pharmacology; D003486:Cyanides / Q000494:pharmacology; D004140:Dinitrophenols / Q000494:pharmacology; D006835:Hydrazones / Q000494:pharmacology; D007700:Kinetics; D008297:Male; D008930:Mitochondria, Liver / Q000187:drug effects / Q000201:enzymology*; D009570:Nitriles / Q000494:pharmacology; D010087:Oxides / Q000494:pharmacology; D010101:Oxygen Consumption / Q000187:drug effects*; D011048:Polarography; D011725:Pyridines / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D012402:Rotenone / Q000494:pharmacology; D014475:Uncoupling Agents / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D001562:Benzimidazoles; D003486:Cyanides; D004140:Dinitrophenols; D006835:Hydrazones; D009570:Nitriles; D010087:Oxides; D011725:Pyridines; D011804:Quinolines; D014475:Uncoupling Agents; D012402:Rotenone; D000968:Antimycin A; D000251:Adenosine Triphosphatases; D000654:Amobarbital